2024 Q4 Form 10-Q Financial Statement

#000089710124000572 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $2.512M
YoY Change 22.12%
Cost Of Revenue $1.247M
YoY Change 17.2%
Gross Profit $1.265M
YoY Change 27.39%
Gross Profit Margin 50.36%
Selling, General & Admin $857.0K
YoY Change 6.99%
% of Gross Profit 67.75%
Research & Development $235.0K
YoY Change 7.8%
% of Gross Profit 18.58%
Depreciation & Amortization $23.00K
YoY Change 15.0%
% of Gross Profit 1.82%
Operating Expenses $1.092M
YoY Change 7.16%
Operating Profit $173.0K
YoY Change -765.38%
Interest Expense $117.0K
YoY Change 6.36%
% of Operating Profit 67.63%
Other Income/Expense, Net $117.0K
YoY Change 7.34%
Pretax Income $290.0K
YoY Change 249.4%
Income Tax $52.00K
% Of Pretax Income 17.93%
Net Earnings $238.0K
YoY Change 2875.0%
Net Earnings / Revenue 9.47%
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $0.07
COMMON SHARES
Basic Shares Outstanding 3.428M shares 3.428M shares
Diluted Shares Outstanding 3.434M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.30M
YoY Change 3.77%
Cash & Equivalents $10.25M
Short-Term Investments $56.00K
Other Short-Term Assets $240.0K
YoY Change -13.98%
Inventory $2.003M
Prepaid Expenses
Receivables $1.182M
Other Receivables $32.00K
Total Short-Term Assets $13.76M
YoY Change 3.88%
LONG-TERM ASSETS
Property, Plant & Equipment $911.0K
YoY Change 0.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $287.0K
YoY Change 43.5%
Total Long-Term Assets $1.198M
YoY Change 8.42%
TOTAL ASSETS
Total Short-Term Assets $13.76M
Total Long-Term Assets $1.198M
Total Assets $14.96M
YoY Change 4.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K
YoY Change -15.71%
Accrued Expenses $639.0K
YoY Change 14.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $859.0K
YoY Change 4.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $859.0K
Total Long-Term Liabilities $0.00
Total Liabilities $859.0K
YoY Change 4.76%
SHAREHOLDERS EQUITY
Retained Earnings $11.43M
YoY Change 4.0%
Common Stock $2.670M
YoY Change 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.10M
YoY Change
Total Liabilities & Shareholders Equity $14.96M
YoY Change 4.23%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $238.0K
YoY Change 2875.0%
Depreciation, Depletion And Amortization $23.00K
YoY Change 15.0%
Cash From Operating Activities $362.0K
YoY Change 57.39%
INVESTING ACTIVITIES
Capital Expenditures $4.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K
YoY Change -99.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 362.0K
Cash From Investing Activities -4.000K
Cash From Financing Activities 0.000
Net Change In Cash 358.0K
YoY Change -121.06%
FREE CASH FLOW
Cash From Operating Activities $362.0K
Capital Expenditures $4.000K
Free Cash Flow $358.0K
YoY Change 55.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
911000 usd
us-gaap Net Income Loss
NetIncomeLoss
80000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1621000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3428021 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
96000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
61000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
238000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-71000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14098000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 usd
dei Local Phone Number
LocalPhoneNumber
930-0100
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
8000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3434417 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
13529000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Net Income Loss
NetIncomeLoss
80000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
13484000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13755000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
175000 shares
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000351789
dei Entity Registrant Name
EntityRegistrantName
ELECTRO SENSORS INC
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-09587
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-0943459
dei Entity Address Address Line1
EntityAddressAddressLine1
6111 Blue Circle Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Minnetonka
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55343-9108
dei City Area Code
CityAreaCode
952
dei Security12b Title
Security12bTitle
Common stock, $0.10 par value
dei Trading Symbol
TradingSymbol
ELSE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3428021 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10246000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9870000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
56000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
56000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1182000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1283000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2003000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1751000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
240000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
179000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
32000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
13759000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
13139000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
287000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
355000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
951000 usd
CY2024Q3 us-gaap Assets
Assets
14957000 usd
CY2023Q4 us-gaap Assets
Assets
14445000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
220000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
291000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
639000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
323000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
76000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
859000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
690000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3428021 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3428021 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3428021 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3428021 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
342000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
342000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2328000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2230000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11428000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11183000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14098000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13755000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14957000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14445000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2512000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2057000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6973000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6239000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1247000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1064000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3581000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3156000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1265000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
993000 usd
us-gaap Gross Profit
GrossProfit
3392000 usd
us-gaap Gross Profit
GrossProfit
3083000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
340000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
307000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1044000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1021000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
517000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
494000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1458000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
235000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
218000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
761000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
724000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1092000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1019000 usd
us-gaap Operating Expenses
OperatingExpenses
3426000 usd
us-gaap Operating Expenses
OperatingExpenses
3203000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
173000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-34000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-120000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
109000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
342000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
297000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
109000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
342000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
296000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
290000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
308000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
176000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
238000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
8000 usd
us-gaap Net Income Loss
NetIncomeLoss
245000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
238000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
245000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
77000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3428021 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3428021 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3428021 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3428021 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3440382 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3428021 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
13829000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
31000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14098000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
38000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
98000 usd
us-gaap Net Income Loss
NetIncomeLoss
245000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
13414000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
38000 usd
us-gaap Net Income Loss
NetIncomeLoss
80000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
13529000 usd
us-gaap Net Income Loss
NetIncomeLoss
245000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
68000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
58000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
98000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
38000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-101000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-95000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
252000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
91000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
65000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
316000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
209000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-108000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-125000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
406000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
255000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
376000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
249000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9870000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9625000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10246000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9874000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
101000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
164000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates</span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 8pt; line-height: inherit;"> </span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; margin: 0pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Current significant estimates, including the underlying assumptions, consist of economic lives of long-lived assets, realizability of trade receivables, and valuation of deferred tax assets/liabilities, inventory, investments, and stock compensation expense. It is at least reasonably possible that these estimates may change in the near term</span>. </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit;">Reclassification of Prior Year Presentation</span></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;">All Treasury Bills from prior periods have been reclassified to cash equivalents for consistency with the current year presentation. The reclassification had no effect on the reported results of operations. The Balance Sheet and Statement of Cash Flows have been adjusted to reflect this reclassification.</p>
else Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
2
CY2024Q3 else Available For Sale Marketable Securities Amortized Cost
AvailableForSaleMarketableSecuritiesAmortizedCost
54000 usd
CY2024Q3 else Available For Sale Marketable Securities Accumulated Gross Unrealized Gain
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain
2000 usd
CY2024Q3 else Available For Sale Marketable Securities Accumulated Gross Unrealized Loss
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss
0 usd
CY2024Q3 us-gaap Marketable Securities
MarketableSecurities
56000 usd
CY2023Q4 else Available For Sale Marketable Securities Amortized Cost
AvailableForSaleMarketableSecuritiesAmortizedCost
54000 usd
CY2023Q4 else Available For Sale Marketable Securities Accumulated Gross Unrealized Gain
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain
2000 usd
CY2023Q4 else Available For Sale Marketable Securities Accumulated Gross Unrealized Loss
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss
0 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
56000 usd
else Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
2
else Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
2
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
56000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
56000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
56000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
56000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1329000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1172000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
299000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
301000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
385000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
288000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
10000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
10000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2003000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1751000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2507 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0465 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
175000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
300000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.11
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
225000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.57
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.04
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
175000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.03
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
95000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.8
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
50000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.21
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1;"><b><span style="font-size: 10pt; line-height: inherit;">Note 6. Contingencies</span></b><span style="font-size: 10pt; line-height: inherit;"></span></p> <p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1;"><span style="font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">The Company at times becomes subject to claims against it in the ordinary course of business. There are currently no pending or threatened claims against the Company that it believes will have a material adverse effect on its results of operations or liquidity.</span></p>

Files In Submission

Name View Source Status
0000897101-24-000572-index-headers.html Edgar Link pending
0000897101-24-000572-index.html Edgar Link pending
0000897101-24-000572.txt Edgar Link pending
0000897101-24-000572-xbrl.zip Edgar Link pending
else-20240930.htm Edgar Link pending
else-20240930.xsd Edgar Link pending
ex311_1.htm Edgar Link pending
ex321_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
else-20240930_cal.xml Edgar Link unprocessable
else-20240930_def.xml Edgar Link unprocessable
else-20240930_lab.xml Edgar Link unprocessable
else-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
else-20240930_htm.xml Edgar Link completed